Figure 1 | Scientific Reports

Figure 1

From: The Sulforaphane and pyridoxamine supplementation normalize endothelial dysfunction associated with type 2 diabetes

Figure 1

Effects of sulforaphane and pyridoxamine treatment on intraperitoneal glucose tolerance test (IPGTT; A), fasting glycaemia (B), the glucose area under the curve (AUC; C) and HbA1c levels (D) in 8 months old diabetic Goto-Kakizaki (GK) rats compared with nondiabetic Wistar (W) rats. C) The AUC of IPGTT curves was calculated to measure the degree of the glucose tolerance impairment. Data are expressed as mean ± SE (n = 12). ***P < 0.001 vs Wistar group; ϕP < 0.05, ϕϕP < 0.01, ϕϕϕP < 0.001 vs GK group.

Back to article page